You might want to take a look at Iovance Biotherapeutics Inc (IOVA) now

With 5.51 million shares changed hands, the volume of the stock remained lighter than its average volume of 9.71 million shares. The 52-week range on IOVA shows that it touched its highest point at $18.33 and its lowest point at $3.21 during that stretch. It currently has a 1-year price target of $26.00. Beta for the stock currently stands at 0.59.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of IOVA was down-trending over the past week, with a drop of -5.23%, but this was down by -17.99% over a month. Three-month performance surged to 69.37% while six-month performance rose 202.64%. The stock gained 123.90% in the past year, while it has gained 69.37% so far this year. A look at the trailing 12-month EPS for IOVA yields -1.89 with Next year EPS estimates of -0.76. For the next quarter, that number is -0.42. This implies an EPS growth rate of 30.65% for this year and 41.97% for next year.

Float and Shares Shorts:

At present, 256.14 million IOVA shares are outstanding with a float of 219.99 million shares on hand for trading. On Mar 15, 2024, short shares totaled 47.43 million, which was 16.98% higher than short shares on Feb 15, 2024. In addition to IOVA as the firm’s Iovance Biotherapeutics, Inc., NOVA serves as its Sunnova Energy International In.

Institutional Ownership:

Through their ownership of 89.20% of IOVA’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for IOVA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, IOVA has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and IOVA currently yields $0.00. In the past year, IOVA’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, IOVA has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.